Startseite>>Signaling Pathways>> Microbiology & Virology>> Parasite>>Nequinate

Nequinate

Katalog-Nr.GC63103

Nequinat, eine Chinolinverbindung, ist ein Antikokzidiose-Mittel gegen Infektionen mit zÖkaler Kokzidiose (Eimeria tenella).

Products are for research use only. Not for human use. We do not sell to patients.

Nequinate Chemische Struktur

Cas No.: 13997-19-8

Größe Preis Lagerbestand Menge
5 mg
45,00 $
Auf Lager
10 mg
67,50 $
Auf Lager
25 mg
108,00 $
Auf Lager
50 mg
171,00 $
Auf Lager
100 mg
270,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Nequinate, a quinoline compound, is an anticoccidial agent against cecal coccidiosis (Eimeria tenella) infections[1]. Nequinate inhibits xanthine oxidoreductase (XOD) activity[2].

Xanthine oxidase (XOD) is a successful and safe drug target for lowering lower serum urate (sUA) levels , it plays an important role in the catabolism of purineNequinate shows an inhibition of 12.0% to inhibit XOD activities[2].

[1]. D K McLoughlin, et al.Efficacy of Nequinate Against Thirteen Strains of Eimeria Tenella and the Development of a Nequinate-Resistant Strain.Avian Dis. Oct-Dec 1973;17(4):717-21.
[2]. Yanfen Niu, et al. Old Drug, New Indication: Olsalazine Sodium Reduced Serum Uric Acid Levels in Mice via Inhibiting Xanthine Oxidoreductase Activity. J Pharmacol Sci. 2017 Nov;135(3):114-120.

Bewertungen

Review for Nequinate

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nequinate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.